| APCs | Antigen-presenting cells |
| ANG2 | Angiopoietin 2 |
| Bat3 | HLA-B-associated transcript 3 |
| B2M | Beta 2 microglobulin |
| Ceacam-1 | Carcinoembyronic antigen-related cell adhesion molecule-1 |
| CTL | Cytotoxic T lymphocytes |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 |
| CXCR3 | C-X-C Motif Chemokine Receptor 3 |
| CXCL9 | C-X-C Motif Chemokine Ligand 9 |
| DCs | Dendritic cells |
| DCreg | Regulatory dendritic cell |
| FCRL6 | Fc receptor-like 6 (protein) |
| FGL-1 | Fibrinogen-like protein 1 |
| Gal-9 | Galectin-9 |
| HDAC | Histone deacetylase |
| HMGB1 | High mobility group protein B1 |
| ICI | Immune checkpoint inhibitors |
| IDO | Indoleamine 2,3-dioxygenase |
| JAK 1, 2 | Janus Kinase 1, 2 |
| LAG-3 | Lymphocyte activation gene 3 |
| LSECtin | Liver sinusoidal endothelial cell lectin |
| MDSCs | Myeloid-derived suppressor cells |
| NK cells | Natural killer cells |
| PD-L1/2 | Programmed death-ligand 1/2 |
| PD-1 | Programmed cell death protein 1 |
| PCSK9 | Subtilisin/kexin type 9 |
| STAT | Signal transducer and activator of transcription |
| SK1 | Sfingosine kinaze 1 |
| S1P | Sphingosine-1-phosphate |
| TCR | T-cell receptor |
| TDO | Tryptophan 2,3-dioxygenase |
| TIGIT | T-cell immunoreceptor with immunoglobulin and ITIM domain |
| TIL | Tumor infiltrating lymphocytes |
| TIM-3 | T cell immunoglobulin and mucin-domain containing molecule-3 |
| TMB | Tumor mutational burden |
| TME | Tumor microenvironment |
| Treg | T regulatory cells |
| VEGF | Vascular endothelial growth factor |